Suzanne M. Hanlon Insider Trading $ZYNE Zynerba Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Suzanne M. Hanlon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Suzanne M. Hanlon. Suzanne M. Hanlon is General Counsel in Zynerba Pharmaceuticals, Inc. ($ZYNE) and Sec, General Counsel & VP HR in Zynerba Pharmaceuticals, Inc. ($ZYNE) and Sec, VP & General Counsel in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Suzanne M. Hanlon in Zynerba Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Suzanne M. Hanlon: Sec, VP & General Counsel, Sec, General Counsel & VP HR, General Counsel
Holdings: 80,693 shares
Current Value: $1,490,400
Latest Transaction: Jan 25 2021
$ZYNE Market Capitalization: $186.92M
$ZYNE Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Suzanne M. Hanlon in Zynerba Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 3.58 | 55,000 | 196,900 | 55,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Grant | A | 0.00 | 37,000 | 0 | 80,693 | 43.7 K to 80.7 K (+84.68 %) |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 5.05 | 60,000 | 303,000 | 60,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 3.65 | 52,859 | 192,935 | 52,859 | |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Buy | P | 5.80 | 3,800 | 22,048 | 43,693 | 39.9 K to 43.7 K (+9.53 %) |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Option Exercise | A | 11.71 | 42,700 | 500,017 | 42,700 | |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Option Exercise | A | 18.22 | 60,000 | 1,093,200 | 60,000 | |
| Aug 17 2016 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Sell | S | 10.53 | 3,000 | 31,590 | 0 | 3 K to 0 (-100.00 %) |
| Aug 17 2016 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Buy | P | 17.92 | 3,000 | 53,760 | 3,000 | 0 to 3 K |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | General Counsel | Option Exercise | A | 14.00 | 46,616 | 652,624 | 46,616 |
Page: 1